IQGAP1 modulates the proliferation and migration of vascular smooth muscle cells in response to estrogen

Huang,Xianchen; Jin,Yiqi; Zhou,Dayong; Xu,Guoxiong; Huang,Jian; Shen,Liming

doi:10.3892/ijmm.2015.2134

IQGAP1 modulates the proliferation and migration of vascular smooth muscle cells in response to estrogen

Authors:
- Xianchen Huang
- Yiqi Jin
- Dayong Zhou
- Guoxiong Xu
- Jian Huang
- Liming Shen
View Affiliations

Affiliations: Department of Vascular Surgery, Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu 215002, P.R. China
Published online on: March 12, 2015 https://doi.org/10.3892/ijmm.2015.2134
Pages: 1460-1466

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Vascular smooth muscle cell (VSMC) proliferation and migration has been proven to be a critical event in the development of varicosity. Variations in estrogen levels, a pathological event related to age and pregnancy, play a role in the pathogenesis of varicosity. Previous studies have reported a different response of VSMCs following estrogen stimulation. However, the exact mechanisms involved have not yet been elucidated. In the present study, we examined the responses of lesion and normal VSMCs treated with 10-8 M 17β-estradiol (E2) for 24 h. A differential effect of exposure to E2 was observed in these cells. IQ-domain GTPase-activating protein 1 (IQGAP1), a scaffold protein, was overexpressed in the lesion VSMCs and was shown to modulate VSMC proliferation and migration in response to E2. Furthermore, the increased expression of IQGAP1 was found to be intimately associated with a high activity of estrogen receptor α (ERα), which has been implicated in the regulation of VSMC physiological function. Additionally, we found that two critical kinases, Akt and extracellular signal-regulated kinase (ERK), mediated the activation of ERα and VSMC proliferation. According to our results, we thus concluded that high levels of IQGAP1 in VSMCs regulate the physiological reaction of the cells in response to estrogen exposure, and that kinases are involved in the process by mediating ERα activation. In view of the essential role of IQGAP1 in the physiological function of VSMCs, targeting this molecule may prove to be a promising strategy for the treatment of varicosity.

View Figures

View References

1	Teng H, Dong J, Li Z and Huang J: Effect of vascular endothelial cells in the occurrence and development of lower extremity varicose veins. China Medical Herald. 10:46–49. 2013.
2	Raffetto JD and Khalil RA: Mechanisms of varicose vein formation: valve dysfunction and wall dilation. Phlebology. 23:85–98. 2008. View Article : Google Scholar : PubMed/NCBI
3	Ruckley CV: Socioeconomic impact of chronic venous insufficiency and leg ulcers. Angiology. 48:67–69. 1997. View Article : Google Scholar : PubMed/NCBI
4	Carpentier PH, Cornu-Thenard A, Uhl JF, Partsch H and Antignani PL: Appraisal of the information content of the C classes of CEAP clinical classification of chronic venous disorders: a multicenter evaluation of 872 patients. J Vasc Surg. 37:827–833. 2003. View Article : Google Scholar : PubMed/NCBI
5	Langer RD, Ho E, Denenberg JO, Fronek A, Allison M and Criqui MH: Relationships between symptoms and venous disease: the San Diego population study. Arch Intern Med. 165:1420–1424. 2005. View Article : Google Scholar : PubMed/NCBI
6	Kurz X, Kahn SR, Abenhaim L, et al: Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management. Summary of an evidence-based report of the VEINES task force Venous Insufficiency Epidemiologic and Economic Studies. Int Angiol. 18:83–102. 1999.PubMed/NCBI
7	Hamdan A: Management of varicose veins and venous insufficiency. Jama. 308:2612–2621. 2012. View Article : Google Scholar : PubMed/NCBI
8	Lee AJ, Evans CJ, Allan PL, Ruckley CV and Fowkes FG: Lifestyle factors and the risk of varicose veins: Edinburgh Vein Study. J Clin Epidemiol. 56:171–179. 2003. View Article : Google Scholar : PubMed/NCBI
9	Cornu-Thenard A, Boivin P, Baud JM, De Vincenzi I and Carpentier PH: Importance of the familial factor in varicose disease. Clinical study of 134 families. J Dermatol Surg Oncol. 20:318–326. 1994. View Article : Google Scholar : PubMed/NCBI
10	White CD, Erdemir HH and Sacks DB: IQGAP1 and its binding proteins control diverse biological functions. Cell Signal. 24:826–834. 2012. View Article : Google Scholar :
11	Owen D, Campbell LJ, Littlefield K, et al: The IQGAP1-Rac1 and IQGAP1-Cdc42 interactions: interfaces differ between the complexes. J Biol Chem. 283:1692–1704. 2008. View Article : Google Scholar
12	Roy M, Li Z and Sacks DB: IQGAP1 binds ERK2 and modulates its activity. J Biol Chem. 279:17329–17337. 2004. View Article : Google Scholar : PubMed/NCBI
13	Roy M, Li Z and Sacks DB: IQGAP1 is a scaffold for mitogen-activated protein kinase signaling. Mol Cell Biol. 25:7940–7952. 2005. View Article : Google Scholar : PubMed/NCBI
14	Ren JG, Li Z and Sacks DB: IQGAP1 modulates activation of B-Raf. Proc Natl Acad Sci USA. 104:10465–10469. 2007. View Article : Google Scholar : PubMed/NCBI
15	Meyer RD, Sacks DB and Rahimi N: IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis. PLoS One. 3:e38482008. View Article : Google Scholar : PubMed/NCBI
16	Noritake J, Watanabe T, Sato K, Wang S and Kaibuchi K: IQGAP1: a key regulator of adhesion and migration. J Cell Sci. 118:2085–2092. 2005. View Article : Google Scholar : PubMed/NCBI
17	Li QY, Chen L, Zhu YH, Zhang M, Wang YP and Wang MW: Involvement of estrogen receptor-beta in farrerol inhibition of rat thoracic aorta vascular smooth muscle cell proliferation. Acta Pharmacol Sin. 32:433–440. 2011. View Article : Google Scholar : PubMed/NCBI
18	Xiao Y, Huang Z, Yin H, Lin Y and Wang S: In vitro differences between smooth muscle cells derived from varicose veins and normal veins. J Vasc Surg. 50:1149–1154. 2009. View Article : Google Scholar : PubMed/NCBI
19	Renno WM, Saleh F and Wali M: A journey across the wall of varicose veins: what physicians do not often see with the naked eye. Med Princ Pract. 15:9–23. 2006. View Article : Google Scholar
20	Cheng Y, Liu X, Yang J, et al: MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res. 105:158–166. 2009. View Article : Google Scholar : PubMed/NCBI
21	Jiang X, Zhang Y, Hou D, et al: 17beta-estradiol inhibits oleic acid-induced rat VSMC proliferation and migration by restoring PGC-1alpha expression. Mol Cell Endocrinol. 315:74–80. 2010. View Article : Google Scholar
22	Branchetti E, Poggio P, Sainger R, et al: Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm. Cardiovasc Res. 100:316–324. 2013. View Article : Google Scholar : PubMed/NCBI
23	Afroze T, Yang G, Khoshbin A, et al: Calcium efflux activity of plasma membrane Ca²⁺ ATPase-4 (PMCA4) mediates cell cycle progression in vascular smooth muscle cells. J Biol Chem. 289:7221–7231. 2014. View Article : Google Scholar : PubMed/NCBI
24	Zhang L, Zhu C, Zhang X, Wan Y and Song J: Dual effects of estrogen on vascular smooth muscle cells: receptor-mediated proliferative vs. metabolite-induced pro-senescent actions. Steroids. 76:309–316. 2011. View Article : Google Scholar
25	Hobbs JT: Letter: varicose veins in developing countries. Lancet. 2:2591976. View Article : Google Scholar : PubMed/NCBI
26	Ahti TM, Makivaara LA, Luukkaala T, Hakama M and Laurikka JO: Lifestyle factors and varicose veins: does cross-sectional design result in underestimate of the risk? Phlebology. 25:201–206. 2010. View Article : Google Scholar : PubMed/NCBI
27	Ciardullo AV, Panico S, Bellati C, et al: High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women. J Vasc Surg. 32:544–549. 2000. View Article : Google Scholar : PubMed/NCBI
28	Wali MA and Eid RA: Changes of elastic and collagen fibers in varicose veins. Int Angiol. 21:337–343. 2002.
29	Bastos AN, Alves MM, Monte-Alto-Costa A, et al: α-smooth muscle actin, fibrillin-1, apoptosis and proliferation detection in primary varicose lower limb veins of women. Int Angiol. 30:262–271. 2011.PubMed/NCBI
30	Han HC: Twisted blood vessels: symptoms, etiology and biomechanical mechanisms. J Vasc Res. 49:185–197. 2012. View Article : Google Scholar : PubMed/NCBI
31	Kowalewski R, Malkowski A, Sobolewski K and Gacko M: Evaluation of transforming growth factor-beta signaling pathway in the wall of normal and varicose veins. Pathobiology. 77:1–6. 2010. View Article : Google Scholar : PubMed/NCBI
32	Ueda K, Lu Q, Baur W, Aronovitz MJ and Karas RH: Rapid estrogen receptor signaling mediates estrogen-induced inhibition of vascular smooth muscle cell proliferation. Arterioscler Thromb Vasc Biol. 33:1837–1843. 2013. View Article : Google Scholar : PubMed/NCBI
33	Zhao J, Imbrie GA, Baur WE, et al: Estrogen receptor-mediated regulation of microRNA inhibits proliferation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 33:257–265. 2013. View Article : Google Scholar :
34	Lewis-Wambi JS and Jordan VC: Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit? Breast Cancer Res. 11:2062009. View Article : Google Scholar : PubMed/NCBI
35	Song J, Wan Y, Rolfe BE, Campbell JH and Campbell GR: Effect of estrogen on vascular smooth muscle cells is dependent upon cellular phenotype. Atherosclerosis. 140:97–104. 1998. View Article : Google Scholar : PubMed/NCBI
36	Mataraza JM, Briggs MW, Li Z, Entwistle A, Ridley AJ and Sacks DB: IQGAP1 promotes cell motility and invasion. J Biol Chem. 278:41237–41245. 2003. View Article : Google Scholar : PubMed/NCBI
37	Kohno T, Urao N, Ashino T, et al: IQGAP1 links PDGF receptor-beta signal to focal adhesions involved in vascular smooth muscle cell migration: role in neointimal formation after vascular injury. Am J Physiol Cell Physiol. 305:C591–C600. 2013. View Article : Google Scholar : PubMed/NCBI
38	Heldring N, Pike A, Andersson S, et al: Estrogen receptors: how do they signal and what are their targets. Physiol Rev. 87:905–931. 2007. View Article : Google Scholar : PubMed/NCBI
39	Erdemir HH, Li Z and Sacks DB: IQGAP1 binds to estrogen receptor-alpha and modulates its function. J Biol Chem. 289:9100–9112. 2014. View Article : Google Scholar : PubMed/NCBI